ES2066547T3 - Peptidos, inmunoquimicamente reactivos con anticuerpos dirigidos contra virus de hepatitis no-a, no-b. - Google Patents

Peptidos, inmunoquimicamente reactivos con anticuerpos dirigidos contra virus de hepatitis no-a, no-b.

Info

Publication number
ES2066547T3
ES2066547T3 ES92200441T ES92200441T ES2066547T3 ES 2066547 T3 ES2066547 T3 ES 2066547T3 ES 92200441 T ES92200441 T ES 92200441T ES 92200441 T ES92200441 T ES 92200441T ES 2066547 T3 ES2066547 T3 ES 2066547T3
Authority
ES
Spain
Prior art keywords
peptides
directed against
antibodies directed
viruses
against hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92200441T
Other languages
English (en)
Inventor
Winand Johannes Antoniu Habets
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2066547T3 publication Critical patent/ES2066547T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION TIENE QUE VER CON PEPTIDOS QUE REACCIONAN INMUNOQUIMICAMENTE CON ANTICUERPOS DIRIGIDOS CONTRA HNANB. METODO PARA LA DETECCION DE HNANB O ANTI-HNANB EN UN FLUIDO DE ANALISIS, UN REAGENTE INMUNOQUIMICO Y UN EQUIPO DE ANALISIS PARA SER UTILIZADO AL APLICAR LOS METODOS DE DETECCION MENCIONADOS PERTENECIENTES A LA INVENCION.
ES92200441T 1991-03-01 1992-02-17 Peptidos, inmunoquimicamente reactivos con anticuerpos dirigidos contra virus de hepatitis no-a, no-b. Expired - Lifetime ES2066547T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200430 1991-03-01

Publications (1)

Publication Number Publication Date
ES2066547T3 true ES2066547T3 (es) 1995-03-01

Family

ID=8207533

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92200441T Expired - Lifetime ES2066547T3 (es) 1991-03-01 1992-02-17 Peptidos, inmunoquimicamente reactivos con anticuerpos dirigidos contra virus de hepatitis no-a, no-b.

Country Status (12)

Country Link
EP (1) EP0501557B1 (es)
JP (1) JPH05331193A (es)
KR (1) KR920018075A (es)
AT (1) ATE112782T1 (es)
AU (1) AU1132292A (es)
CA (1) CA2062097A1 (es)
DE (1) DE69200512T2 (es)
DK (1) DK0501557T3 (es)
ES (1) ES2066547T3 (es)
FI (1) FI920910A7 (es)
IE (1) IE65424B1 (es)
ZA (1) ZA921175B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0644202T3 (da) * 1990-12-14 1997-09-15 Innogenetics Nv Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
EP1357127A1 (de) * 2002-04-10 2003-10-29 Immusystems GmbH CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
ATE211772T1 (de) * 1989-05-18 2002-01-15 Chiron Corp Nanbv-diagnostika: polynukleotide, geeignet für reihenuntersuchungen auf hepatitis c-virus

Also Published As

Publication number Publication date
IE65424B1 (en) 1995-10-18
ATE112782T1 (de) 1994-10-15
EP0501557A1 (en) 1992-09-02
AU1132292A (en) 1992-09-03
DK0501557T3 (da) 1995-04-10
FI920910L (fi) 1992-09-02
FI920910A0 (fi) 1992-02-28
CA2062097A1 (en) 1992-09-02
KR920018075A (ko) 1992-10-21
ZA921175B (en) 1992-11-25
DE69200512T2 (de) 1995-03-09
FI920910A7 (fi) 1992-09-02
JPH05331193A (ja) 1993-12-14
DE69200512D1 (de) 1994-11-17
IE920500A1 (en) 1992-09-09
EP0501557B1 (en) 1994-10-12

Similar Documents

Publication Publication Date Title
DE69527959D1 (de) Nachweis von Retikulozyten mit Coriphosphin O
ES2013226T3 (es) Una composicion que genera luz al activarse y su metodo de preparacion.
ES554453A0 (es) Un metodo para detectar la presencia de virus lav-htlv-iii o de anticuerpo para virus lav-htlv-iii
EA199700126A1 (ru) Вакцина против гепатита в
ATE189939T1 (de) Hochempfindlicher molekular identifikator
ES2080099T3 (es) Ensayo para la hepatitis c.
DK52483A (da) Immunoanalytisk fremgangsmaade til bestemmelse af antigen-koncentra tioner i oploesning, samt materialer og udstyr til anvendelse ved remgangsmaaden
ES2055204T3 (es) Conservante liquido.
ES2066547T3 (es) Peptidos, inmunoquimicamente reactivos con anticuerpos dirigidos contra virus de hepatitis no-a, no-b.
DK157218C (da) Fremgangsmaade til paavisning eller bestemmelse af histamin i legemsvaesker navnlig blod eller blodfraktioner, samt analyseanordning til anvendelse ved idoevelse af fremgangsmaaden
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
DK0552829T3 (da) CENP-B-peptid
ES2070415T3 (es) Peptidos inmunoquimicamente reactivos con anticuerpos dirigidos contra el virus de la hepatitis no-a, no-b.
ES2069298T3 (es) Secuencias no-a no-b.
Smith Detection methods for rodent viruses.
EP0362909A3 (en) Synthetic polypeptides immunochemically reactive with hiv-antibodies
EP0362927A3 (en) Synthetic polypeptides immunochemically reactive with hiv antibodies
FI865165A7 (fi) Menetelmä ja reagenssi testosteronin määrittämiseksi sekä sen vasta-aineet.
ES2102342T1 (es) Peptido capaz de ser reconocido por unos anticuerpos que reconocen el antigeno c33 del virus de la hepatitis c.
DK316089A (da) Fremgangsmaade til paavisning af antistoffer eller antigener i et testfluidum samt proevesaet til anvendelse ved fremgangsmaaden
ATA150689A (de) Optoelektronische messvorrichtung zur punktfoermigen erfassung von dosis, dosisleistung und dosisverteilungen
EP0362910A3 (en) Synthetic peptides immunochemically reactive with hiv-antibodies
FI952779L (fi) HCV:n C33-alueen peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
DE68901493D1 (de) Vorrichtung zur messung der energie eines lichtbogens.
IT8223830A0 (it) Metodo per proteggere monumenti culturali e naturali, reliquie o oggetti, e un dispositivo per effettuare il metodo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 501557

Country of ref document: ES